Tracking David Rolfe’s Wedgewood Partners Portfolio – Q2 2024 Update

  • Wedgewood Partners’ 13F portfolio value decreased from ~$500M to ~$490M this quarter.
  • They increased Edwards Lifesciences (EW) while decreasing Motorola Solutions (MSI).
  • Their top five positions are at 40% of the overall portfolio.

This article is part of a series that provides an ongoing analysis of the changes made to Wedgewood Partners’ 13F stock portfolio on a quarterly basis. It is based on David Rolfe’s regulatory 13F Form filed on 08/14/2024. The 13F portfolio value decreased from $500M to $490M this quarter. The holdings are concentrated with recent 13F reports showing around 20 positions. The largest five stakes are Meta Platforms (META), Alphabet (GOOG), Taiwan Semi (TSM), Apple (AAPL), and Visa (V). They add up to ~40% of the portfolio. Please visit our Tracking David Rolfe’s Wedgewood Partners Portfolio series to get an idea of their investment philosophy and our last update for the fund’s moves during Q1 2024. Wedgewood has generated significant alpha since its 1992 inception. David Rolfe also sub-advises Riverpark/Wedgewood Fund (RWGIX) (RWGFX) as portfolio manager, a mutual fund incepted in 2010.

 

To learn about individual investing, check out the classics The Intelligent Investor and Security Analysis.

 

 

The spreadsheet below highlights changes to David Rolfe’s US stock holdings in Q2 2024:

 

 


 

Source: John Vincent. Data constructed from Wedgewood Partners’ 13F filings for Q1 2024 and Q2 2024.

No comments :

Post a Comment